Your browser doesn't support javascript.
loading
Cardiac myosin inhibitors for hypertrophic cardiomyopathy: shedding light on their clinical potential.
Rao, Shiavax J; Forst, Beani; Kanwal, Amreen K; Kanwal, Arjun; Aronow, Wilbert S; Naidu, Srihari S.
Affiliation
  • Rao SJ; Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD, USA.
  • Forst B; Department of Medicine, Creighton University Arizona Health Education Alliance, Phoenix, Az, USA.
  • Kanwal AK; Tufts University School of Medicine, Boston, MA, USA.
  • Kanwal A; Department of Cardiology, Westchester Medical Center, Valhalla, NY, USA.
  • Aronow WS; Department of Cardiology, Westchester Medical Center and Department of Medicine, New York Medical College, Valhalla, NY, USA.
  • Naidu SS; Hypertrophic Cardiomyopathy Center, Cardiac Catheterization Laboratory, Department of Cardiology, Westchester Medical Center and Department of Medicine, New York Medical College, Valhalla, NY, USA.
Expert Opin Investig Drugs ; 32(1): 1-4, 2023 01.
Article in En | MEDLINE | ID: mdl-36625220

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiomyopathy, Hypertrophic / Cardiac Myosins Limits: Humans Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiomyopathy, Hypertrophic / Cardiac Myosins Limits: Humans Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: United States